Mel Symeonides
@msymeonides.bsky.social
Assistant Prof at the University of Vermont, interested in HIV latency, syncytia, placenta etc. Opinions = my own.
Reposted by Mel Symeonides
How HIV research drives health innovation in multiple diseases
The future of HIV research — and of the USA’s scientific leadership — depends on bold, sustained action in defense of discovery, investment, and innovation.
www.nature.com/artic...
1/2
The future of HIV research — and of the USA’s scientific leadership — depends on bold, sustained action in defense of discovery, investment, and innovation.
www.nature.com/artic...
1/2
How HIV research drives health innovation in multiple diseases | Nature Medicine
The future of HIV research — and of the USA’s scientific leadership — depends on bold, sustained action in defense of discovery, investment, and innovation.
www.nature.com
October 25, 2025 at 9:31 AM
How HIV research drives health innovation in multiple diseases
The future of HIV research — and of the USA’s scientific leadership — depends on bold, sustained action in defense of discovery, investment, and innovation.
www.nature.com/artic...
1/2
The future of HIV research — and of the USA’s scientific leadership — depends on bold, sustained action in defense of discovery, investment, and innovation.
www.nature.com/artic...
1/2
Three abstracts submitted for CSH Retroviruses this year! Particularly excited about one of them as it came together in the nick of time, but all three are going to be bangers.
March 1, 2025 at 1:21 PM
Three abstracts submitted for CSH Retroviruses this year! Particularly excited about one of them as it came together in the nick of time, but all three are going to be bangers.
What if the indirect cost model is truly broken and wasteful... AND the idea that it would be cut to 15% across the board with 3 days' notice is just about the worst way possible to address this problem?
February 8, 2025 at 5:34 PM
What if the indirect cost model is truly broken and wasteful... AND the idea that it would be cut to 15% across the board with 3 days' notice is just about the worst way possible to address this problem?
Quoting this paper:
Viral rebound has also been described in untreated individuals (24, 25), but often at a lower frequency compared with N-R treated individuals regardless of rebound definition (6, 17, 19, 20, 22, 23, 26, 27).
Viral rebound has also been described in untreated individuals (24, 25), but often at a lower frequency compared with N-R treated individuals regardless of rebound definition (6, 17, 19, 20, 22, 23, 26, 27).
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance journals.asm.org/doi/10.1128/...
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance | Journal of Virology
Nirmatrelvir-ritonavir is an effective treatment for SARS-CoV-2. In a subset of individuals
treated with nirmatrelvir-ritonavir, the initial reduction in viral load is followed
by viral rebound once t...
journals.asm.org
February 5, 2025 at 7:07 PM
Quoting this paper:
Viral rebound has also been described in untreated individuals (24, 25), but often at a lower frequency compared with N-R treated individuals regardless of rebound definition (6, 17, 19, 20, 22, 23, 26, 27).
Viral rebound has also been described in untreated individuals (24, 25), but often at a lower frequency compared with N-R treated individuals regardless of rebound definition (6, 17, 19, 20, 22, 23, 26, 27).
I can't decide what's worse when coding with ChatGPT: ChatGPT-4 being maliciously lazy, or ChatGPT-3.5 being just straight dumb? Either way, what a waste of time (and money).
March 2, 2024 at 9:17 PM
I can't decide what's worse when coding with ChatGPT: ChatGPT-4 being maliciously lazy, or ChatGPT-3.5 being just straight dumb? Either way, what a waste of time (and money).
Dear Outlook, no I do not want to send a read receipt for an email I just marked as Junk.
January 22, 2024 at 2:57 PM
Dear Outlook, no I do not want to send a read receipt for an email I just marked as Junk.
I have my issues with FlowJo, but the new version that just came out with spectral plots is pretty damn cool!!!
November 29, 2023 at 4:27 PM
I have my issues with FlowJo, but the new version that just came out with spectral plots is pretty damn cool!!!
Reposted by Mel Symeonides
My "Friends don't let friends make bad graphs" repository has reached 1000+ stars on GitHub! I can't believe it! Thanks everyone for the interest and support. Gonna add this to my CV. 😂😂😂
github.com/cxli233/Frie...
github.com/cxli233/Frie...
November 20, 2023 at 1:32 AM
My "Friends don't let friends make bad graphs" repository has reached 1000+ stars on GitHub! I can't believe it! Thanks everyone for the interest and support. Gonna add this to my CV. 😂😂😂
github.com/cxli233/Frie...
github.com/cxli233/Frie...
Note to self: Clone the damn thing in the right way round next time. 🤦♂️🤦♂️🤦♂️
October 15, 2023 at 2:47 AM
Note to self: Clone the damn thing in the right way round next time. 🤦♂️🤦♂️🤦♂️
This place is so much better than X (cesspool of misinfo and rage) and Mastodon (deader than the actual animal it's named after). Let's get all the good people over here!
September 30, 2023 at 3:29 PM
This place is so much better than X (cesspool of misinfo and rage) and Mastodon (deader than the actual animal it's named after). Let's get all the good people over here!